Sitagliptin Phosphate Monohydrate
Home / API - Under Development / Sitagliptin Phosphate Monohydrate
CAS No.
486460-32-6
Therapeutic Category
- Anti-diabetic
Innovator Brand
Janumet, Janumet XR
GMP
Available
DMF
Not Available
Filed
-
Under Filing
-
Sample
Available
Indication
Sitagliptin Phosphate Monohydrate, is an anti-diabetic medication developed by Merck & Co used to treat type 2 diabetes.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.